BioPharma Credit (LON:BPCR – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 1 and last traded at GBX 0.97, with a volume of 813598 shares traded. The stock had previously closed at GBX 0.97.
BioPharma Credit Price Performance
The stock has a 50-day moving average of GBX 0.96 and a 200 day moving average of GBX 0.94. The company has a market cap of £10.89 million, a P/E ratio of 0.09 and a beta of 0.22.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than BioPharma Credit
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
